Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 1
2006 1
2007 1
2009 2
2010 3
2011 4
2012 3
2013 6
2014 4
2015 6
2016 7
2017 7
2018 28
2019 8
2020 21
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Results by year
Filters applied: . Clear all
Page 1
Eteplirsen in the treatment of Duchenne muscular dystrophy.
Lim KR, Maruyama R, Yokota T. Lim KR, et al. Among authors: yokota t. Drug Des Devel Ther. 2017 Feb 28;11:533-545. doi: 10.2147/DDDT.S97635. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28280301 Free PMC article. Review.
Muscular Dystrophy: Disease Mechanisms and Therapies.
Pandey SN, Kesari A, Yokota T, Pandey GS. Pandey SN, et al. Among authors: yokota t. Biomed Res Int. 2015;2015:456348. doi: 10.1155/2015/456348. Epub 2015 Aug 24. Biomed Res Int. 2015. PMID: 26380274 Free PMC article. No abstract available.
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy.
Lim KRQ, Yoon C, Yokota T. Lim KRQ, et al. Among authors: yokota t. J Pers Med. 2018 Nov 24;8(4):38. doi: 10.3390/jpm8040038. J Pers Med. 2018. PMID: 30477208 Free PMC article. Review.
Nusinersen in the Treatment of Spinal Muscular Atrophy.
Goodkey K, Aslesh T, Maruyama R, Yokota T. Goodkey K, et al. Among authors: yokota t. Methods Mol Biol. 2018;1828:69-76. doi: 10.1007/978-1-4939-8651-4_4. Methods Mol Biol. 2018. PMID: 30171535 Review.
DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.
Lim KRQ, Nguyen Q, Yokota T. Lim KRQ, et al. Among authors: yokota t. Int J Mol Sci. 2020 Jan 22;21(3):729. doi: 10.3390/ijms21030729. Int J Mol Sci. 2020. PMID: 31979100 Free PMC article. Review.
Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies.
Nguyen Q, Lim KRQ, Yokota T. Nguyen Q, et al. Among authors: yokota t. Int J Mol Sci. 2020 Jan 22;21(3):733. doi: 10.3390/ijms21030733. Int J Mol Sci. 2020. PMID: 31979133 Free PMC article. Review.
Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.
Dzierlega K, Yokota T. Dzierlega K, et al. Among authors: yokota t. Gene Ther. 2020 Sep;27(9):407-416. doi: 10.1038/s41434-020-0156-6. Epub 2020 Jun 1. Gene Ther. 2020. PMID: 32483212 Review.
Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches.
Shimizu-Motohashi Y, Komaki H, Motohashi N, Takeda S, Yokota T, Aoki Y. Shimizu-Motohashi Y, et al. Among authors: yokota t. J Pers Med. 2019 Jan 7;9(1):1. doi: 10.3390/jpm9010001. J Pers Med. 2019. PMID: 30621068 Free PMC article. Review.
Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophies.
Hwang J, Yokota T. Hwang J, et al. Among authors: yokota t. Expert Rev Mol Med. 2019 Oct 2;21:e5. doi: 10.1017/erm.2019.5. Expert Rev Mol Med. 2019. PMID: 31576784 Review.
An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
Rodrigues M, Yokota T. Rodrigues M, et al. Among authors: yokota t. Methods Mol Biol. 2018;1828:31-55. doi: 10.1007/978-1-4939-8651-4_2. Methods Mol Biol. 2018. PMID: 30171533 Review.
102 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback